Search

everythinglearnresearchcommunity

for

Search:↓

Hirsutism is when women have too much hair growth, often due to a bit more androgen hormones and sensitive skin.

FAGA diagnosis uses blood tests and trichoscopy, with treatments like topical minoxidil, oral anti-androgens, and hormone-modulating drugs.

Insulin resistance is linked to high male hormone levels in women, often seen in those with PCOS.

Microparticles containing artocarpin extract could effectively treat hair loss and acne with minimal side effects.

Most hirsutism cases are due to PCOS, and treatment focuses on lowering testosterone and blocking its effects.

Aromatase inhibitors cause male pattern hair loss in women.

Advancements in male reproductive medicine are ongoing, but more research and improved treatments are needed in several areas.

Male pattern baldness may be caused by scalp pressure on hair follicles, which increases with age and leads to a cycle of hair loss. This process is not directly determined by genes.

AGA affects many, progresses differently, and early treatment is crucial.

Flutamide, an antiandrogen, has minimal impact on female rat endocrine systems and does not significantly change their reproductive cycles.

Dihydrotestosterone makes arteries stiffer in female mice by reducing estrogen receptor expression.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might reduce it. AST decreases recurrence-free survival but doesn't affect overall survival or progression-free survival. More research is needed to understand AST's benefits.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might decrease the risk. AST also lessens the chance of cancer coming back but doesn't really affect survival rates. More research is needed to understand AST's benefits for different bladder cancers.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

Most women with excess hair growth have an underlying hormonal issue, often treated with medication and hair removal methods.

Spironolactone is a safe and effective treatment for reducing excessive hair growth in women.

Finasteride safely lowers DHT levels without affecting testosterone.

Hormones and metabolism play a complex role in prostate enlargement, and more research is needed to improve diagnosis and treatment.

Hormonal treatments can help with acne but are not the first choice due to side effects and the need for careful patient selection.

Hormones, especially androgens, play a key role in acne, which can be a symptom of systemic diseases like PCOS and may require targeted treatment.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

Oestrogens help maintain healthy skin, heal wounds, and may protect against skin aging and cancer.

ADT, especially enzalutamide, may increase the risk of heart rhythm problems and sudden death in men.

The TRPV3 gene mutation affects hair growth by keeping mice in the growth phase longer, which could help treat hair loss.

Androstanediol glucuronide is a reliable marker for hirsutism in women.

Medicines that lower androgen levels and hair removal treatments help manage excessive hair and acne in women with PCOS.

DHT, a testosterone byproduct, causes male pattern baldness.

Spironolactone improved blood vessel function and cholesterol levels in non-obese women with PCOS.

Cyproterone acetate plus ethinyl estradiol is generally more effective in treating hirsutism, but consider side effects and patient characteristics.

Hair diversity is influenced by complex genetics and environmental factors, requiring more research for practical solutions.